HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 1,201-1,212 of 7,264
Drug study icon
Not Yet RecruitingACTRN12626001250325

A Study Evaluating the Effect of Food on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PNV-8297 in Healthy Volunteers

Official study title

A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Effect of Food on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PNV-8297 in Healthy Volunteers

This study isn't recruiting yet.

In Australia
DepressionInterventional studyAges 18–65
Countries
Australia
Sponsor
ProNovo Therapeutics Australia Pty Ltd
Drug study icon
Not Yet RecruitingACTRN12626001249347

Safety study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PNV-8297 in Depression

Official study title

A Randomised, Double-Blind, Placebo-Controlled, Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PNV-8297 in Healthy Volunteers

This study isn't recruiting yet.

In Australia
DepressionInterventional studyAges 18–65
Countries
Australia
Sponsor
ProNovo Therapeutics Australia Pty Ltd
Drug study icon
Not Yet RecruitingACTRN12625001326482

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GM-28K in Healthy Adult Participants

Official study title

A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GM-28K in Healthy Adult Participants

This study isn't recruiting yet.

In Australia
DepressionInterventional studyAges 18–55
Countries
Australia
Sponsor
Grey Matter Pharma Pty Ltd
Device study icon
CompletedACTRN12610000998044

A study evaluating the efficacy of right unilateral and bilateral repetitive transcranial magnetic stimulation for depression.

Official study title

A comparative trial of sequential bilateral and unilateral right sided priming repetitive transcranial magnetic stimulation on the severity of depressive symptoms in major depressive disorder.

This study has finished and is no longer accepting participants.

Location not clearly listed
DepressionInterventional studyAges 18–70
Countries
Sponsor
Healthscope
Other study type icon
Enrolling By InvitationNCT01809080

Intern Health Study

Official study title

Investigation Into the Interaction Between Genes and Stress in the Etiology of Depression in Interns

This study is by invitation only.

In Ann Arbor
DepressionObservational study
Countries
United States
Sponsor
University of Michigan
Drug study icon
Not recruitingEUCTR 2016-001637-27

A randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression.

This study isn't currently recruiting.

Recruitment status comes from the linked ISRCTN record. Both registries list the identifiers for the same study.

In United Kingdom
DepressionHistorical research record
Countries
United Kingdom
Sponsor
South London and Maudsley NHS Foundation Trust [...] 1. South London and Maudsley NHS Foundation Trust 2. King's College London
Drug study icon
TerminatedNCT04821271

Antidepressant Effects of TS-161 in Treatment-Resistant Depression

Official study title

An Investigation of the Antidepressant Effects of the mGlu2/3 Receptor Antagonist TS-161 in Treatment-Resistant Depression

This study ended early.

In Bethesda
DepressionMedication studyAges 18–65
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.